Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1.

Kalakonda N, Fischle W, Boccuni P, Gurvich N, Hoya-Arias R, Zhao X, Miyata Y, Macgrogan D, Zhang J, Sims JK, Rice JC, Nimer SD.

Oncogene. 2008 Jul 17;27(31):4293-304. doi: 10.1038/onc.2008.67. Epub 2008 Apr 14.

2.

L3MBTL1, a histone-methylation-dependent chromatin lock.

Trojer P, Li G, Sims RJ 3rd, Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, Wang YH, Reinberg D.

Cell. 2007 Jun 1;129(5):915-28.

3.

Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells.

Jankovic V, Ciarrocchi A, Boccuni P, DeBlasio T, Benezra R, Nimer SD.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1260-5. Epub 2007 Jan 16.

4.

Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.

Araki H, Yoshinaga K, Boccuni P, Zhao Y, Hoffman R, Mahmud N.

Blood. 2007 Apr 15;109(8):3570-8. Epub 2006 Dec 21.

PMID:
17185465
5.

Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis.

Saunthararajah Y, Boccuni P, Nucifora G.

Crit Rev Eukaryot Gene Expr. 2006;16(2):183-92. Review.

PMID:
16749897
6.

Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.

Scandura JM, Boccuni P, Massagué J, Nimer SD.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15231-6. Epub 2004 Oct 11. Erratum in: Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16707.

7.

Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.

MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD.

Genes Chromosomes Cancer. 2004 Nov;41(3):203-13.

PMID:
15334543
8.

Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.

Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.

J Leukoc Biol. 2004 Sep;76(3):623-33. Epub 2004 Jun 14.

PMID:
15197237
9.

Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets.

Wang WK, Tereshko V, Boccuni P, MacGrogan D, Nimer SD, Patel DJ.

Structure. 2003 Jul;11(7):775-89.

10.

The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).

Boccuni P, MacGrogan D, Scandura JM, Nimer SD.

J Biol Chem. 2003 Apr 25;278(17):15412-20. Epub 2003 Feb 14.

11.

Transcription factor fusions in acute leukemia: variations on a theme.

Scandura JM, Boccuni P, Cammenga J, Nimer SD.

Oncogene. 2002 May 13;21(21):3422-44. Review.

12.

Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.

Di Noto R, Pane F, Camera A, Luciano L, Barone M, Lo Pardo C, Boccuni P, Intrieri M, Izzo B, Villa MR, MacrĂ­ M, Rotoli B, Sacchetti L, Salvatore F, Del Vecchio L.

Leukemia. 2001 Oct;15(10):1641-9.

13.

Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle.

Miyazaki Y, Boccuni P, Mao S, Zhang J, Erdjument-Bromage H, Tempst P, Kiyokawa H, Nimer SD.

J Biol Chem. 2001 Nov 2;276(44):40528-36. Epub 2001 Aug 14.

14.

Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.

Camera A, Pezzullo L, Villa MR, Luciano L, Pane F, Izzo B, Boccuni P, Di Noto R, Del Vecchio L, Salvatore F, Rotoli B.

Haematologica. 2000 May;85(5):496-501.

15.

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.

Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Coco F.

J Clin Oncol. 2000 Mar;18(6):1295-300.

PMID:
10715300
16.

Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.

Boccuni P, Del Vecchio L, Di Noto R, Rotoli B.

Crit Rev Oncol Hematol. 2000 Jan;33(1):25-43. Review.

PMID:
10714960
17.

In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.

Di Noto R, Boccuni P, Costantini S, Dello Russo A, Lo Pardo C, Copia C, Annunziata M, Cimino R, Ferrara F, Del Vecchio L.

Tissue Antigens. 1999 Dec;54(6):597-602.

PMID:
10674975
18.

Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.

Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR, Kumar MS, Rosenfeld S, Young NS.

Ann Intern Med. 1999 Sep 21;131(6):401-8.

PMID:
10498555
19.

Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.

Ferrara F, Di Noto R, Viola A, Russo C, Boccuni P, Costantini S, Dello Russo A, Lo Pardo C, Del Vecchio L.

Br J Haematol. 1999 Aug;106(2):520-3.

PMID:
10460615
20.

CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.

Boccuni P, Di Noto R, Lo Pardo C, Villa MR, Ferrara F, Rotoli B, Del Vecchio L.

Tissue Antigens. 1998 Jul;52(1):1-8.

PMID:
9714468
21.

Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.

Ferrara F, Di Noto R, Annunziata M, Copia C, Lo Pardo C, Boccuni P, Sebastio L, Del Vecchio L.

Br J Haematol. 1998 Jul;102(2):444-8.

PMID:
9695958
22.

Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.

Alfinito F, Del Vecchio L, Rocco S, Boccuni P, Musto P, Rotoli B.

Leukemia. 1996 Aug;10(8):1326-30.

PMID:
8709638
23.

The PIG-A gene somatic mutation responsible for paroxysmal nocturnal hemoglobinuria.

Rotoli B, Boccuni P.

Haematologica. 1995 Nov-Dec;80(6):539-45. Review.

Supplemental Content

Loading ...
Support Center